Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:19 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Assessment of Valproate on Ethanol Withdrawal
NCT03235531 · CAMC Health System · PHASE4 · terminated · last registry update 2026-08-18 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “PI left site without transferring study to another PI. Study expired and was not renewed.” | – | Registry record, CAMC Health System |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against ALDH5A1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-11-05Results posted on the registry: M.D. Anderson Cancer Center, Bevacizumab + Cetuximab (NCT01552434)
- 2026-11-05Also stopped (terminated): M.D. Anderson Cancer Center, Bevacizumab + Cetuximab (NCT01552434)
- 2026-11-05Also stopped (terminated): Dr. Inge Winter, Clozapine + Esketamine Nasal Product (NCT05603104)
- 2026-10-21Also stopped (suspended): Virginia Commonwealth University, Neratinib + Divalproex Sodium (NCT03919292)
- 2026-08-17Also stopped (terminated): University of Leicester, Sodium Valproate (NCT03825250)
- 2025-11-14Results posted on the registry: University of North Carolina, Chapel Hill, Phenobarbital Sodium Injection + Levetiracetam (NCT06081283)
- 2025-11-14Also stopped (terminated): University of North Carolina, Chapel Hill, Phenobarbital Sodium Injection + Levetiracetam (NCT06081283)
- 2025-09-10Phase 3 first posted: Northwestern University, Valproic Acid (VPA) (NCT07166393)
- 2025-08-26Phase 3 first posted: Bristol-Myers Squibb, Xanomeline/Trospium Chloride + Placebo (NCT07140913)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision